Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
about
Therapeutic Oligonucleotides Targeting Liver Disease: TTR AmyloidosisExcision of HIV-1 proviral DNA by recombinant cell permeable tre-recombinaseCell penetrating peptides in the delivery of biopharmaceuticals.Delivery of macromolecules into live cells by simple co-incubation with a peptideProtein transport across membranes: Comparison between lysine and guanidinium-rich carriers.MITF-siRNA formulation is a safe and effective therapy for human melasmaA novel role for progesterone and progesterone receptor membrane component 1 in regulating spindle microtubule stability during rat and human ovarian cell mitosis.Targeting acute myeloid leukemia with a proapoptotic peptide conjugated to a Toll-like receptor 2-mediated cell-penetrating peptide.In vitro efficient transfection by CM₁₈-Tat₁₁ hybrid peptide: a new tool for gene-delivery applicationsDesign of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivoTumor-targeted RNA-interference: functional non-viral nanovectors.A peptide-based vector for efficient gene transfer in vitro and in vivo.Serum stability and physicochemical characterization of a novel amphipathic peptide C6M1 for siRNA delivery.Synergistic silencing: combinations of lipid-like materials for efficacious siRNA deliveryPeptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.A role for peptides in overcoming endosomal entrapment in siRNA delivery - A focus on melittinCPP2-p16MIS treatment-induced colon carcinoma cell death in vitro and prolonged lifespan of tumor-bearing mice.PEP-1-MsrA ameliorates inflammation and reduces atherosclerosis in apolipoprotein E deficient mice.A membrane penetrating peptide aptamer inhibits STAT3 function and suppresses the growth of STAT3 addicted tumor cells.Functional Delivery of siRNA by Disulfide-Constrained Cyclic Amphipathic Peptides.Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics.Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems.Relevance of biophysical interactions of nanoparticles with a model membrane in predicting cellular uptake: study with TAT peptide-conjugated nanoparticles.A comparison of peptide and folate receptor targeting of cancer cells: from single agent to nanoparticle.Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides.Cell-penetrating peptides as a novel transdermal drug delivery system.Exploitation of viral properties for intracellular delivery.Sequence-defined shuttles for targeted nucleic acid and protein delivery.Peptide nucleic acid (PNA) cell penetrating peptide (CPP) conjugates as carriers for cellular delivery of antisense oligomers.Development of protein mimics for intracellular delivery.High-Yield Synthesis of Monomeric LMWP(CPP)-siRNA Covalent Conjugate for Effective Cytosolic Delivery of siRNA.Sequence segregation improves non-covalent protein delivery.Cell-Penetrating Peptides-Mechanisms of Cellular Uptake and Generation of Delivery Systems.Covalent and Non-Covalent DNA-Gold-Nanoparticle Interactions: New Avenues of Research.Functional properties of a novel hybrid antimicrobial peptide NS: potent antitumor activity and efficient plasmid delivery.Insights into the uptake mechanism of NrTP, a cell-penetrating peptide preferentially targeting the nucleolus of tumour cells.Increased RNAi is related to intracellular release of siRNA via a covalently attached signal peptide.Evaluation of Cell Penetrating Peptide Delivery System on HPV16E7 Expression in Three Types of Cell LinePeptide-lipid interactions: experiments and applications.Development of Guanidinium-Rich Protein Mimics for Efficient siRNA Delivery into Human T Cells.
P2860
Q26782089-7FBBF4DE-CC67-4C73-AC1A-1ECA0E9057C1Q28480614-EBAC228A-14D5-422D-802C-8587D3EF8A0DQ33649501-45E35DD7-2C81-4C48-BCB5-676A2CEBB832Q34047649-F4409C4B-1FF6-4487-9D0F-2432187963EBQ34492665-46061DF0-6637-40E6-9EF8-2F9434037A60Q34556920-DC413A7D-C40C-4D48-8AD4-590CCA450DB9Q34705712-B35A1ADC-70B8-45D3-9DFC-204284D83B07Q34818576-3F080858-AD08-4B33-879F-F17CDBAF2E34Q34905867-69D106EF-147D-4988-9B17-B089D82A493DQ34946937-708A7C3B-D5A3-4091-9848-5A476D97062AQ34974957-3759B6CA-9797-4012-87A0-D7F2EEC6295DQ35144408-6CD01B02-150D-42AC-862D-9158DBDDA3C6Q35169140-7D7799A7-354A-4E74-9C50-B6369A99A4EDQ35238275-26C877B8-3091-4740-BB09-B76F413256CEQ35783096-6702A940-6566-49A8-B412-CDC3DC1B20CAQ35967737-2F81AEF4-C4CE-4A57-9D4C-6D1760366C27Q36093248-2AB03B17-C465-434A-8F0D-BCF8F34F6378Q36095865-D4E7F8ED-7594-4DC7-90D4-23EFF9CB45CDQ36894985-34B9DB33-1246-4E4C-A5DF-0E4779787445Q36996266-32BD3396-19A5-4EF2-B399-6DB668AE99FFQ37230918-B2119298-72CD-424A-A2E2-32A128F1A13FQ37347451-AF78534A-5388-4C50-A953-F17CBB87B636Q37376298-EA5C9415-1C8E-4A01-AF97-61E54B8BD8B8Q37838443-D1FB2527-A866-4BEE-8966-454AE726C440Q37944929-FBCA102F-8CEB-4312-BD1D-4FC2D6CA018BQ38030731-48D655B0-F654-4C55-9714-F4FA27475812Q38216947-6CAD0FEE-EFFA-46DC-8A63-67142266B491Q38265619-AA02E840-FF29-4A38-ADB7-60294C293959Q38325571-EA015DBD-3221-45A6-B357-A8979A230134Q38413685-E70C39E2-F9C4-4CEF-B7A6-5029A285B83AQ38651811-74E1E0F9-0A32-4F80-A2B8-B73A7D5A6025Q38709478-9741B196-FE00-442A-BF00-CC5D2B9EFC0AQ38974236-8042FC65-6C61-478D-8EEB-3A8C5C25D98DQ38977153-E7F21160-6FEF-4FD6-8A1E-333D012CF13BQ38981834-05F49D48-9A05-42EC-A847-082C7E1EA744Q39382518-B5A41774-1563-49F8-8CD1-A9D6840003DDQ39882078-87ECCDC7-9542-4723-8E62-D0A9DF396EE8Q41674446-9C53C29B-6C92-4345-B300-6932A32A0481Q42017138-F0FA5DF2-009F-45E1-B401-E3448F570327Q42222936-A67033F9-AE27-41AF-8E9A-8D27DA190C8F
P2860
Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 October 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
@en
Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
@nl
type
label
Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
@en
Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
@nl
prefLabel
Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
@en
Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
@nl
P1476
Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy
@en
P2093
Frédéric Heitz
Gilles Divita
P304
P356
10.1016/J.ADDR.2007.09.005
P407
P577
2007-10-25T00:00:00Z